Search


	Podcast:		Trillions
	Episode:		ETFs Get Trippy in the Shroom Sector
	Category:		Business
	Duration:		00:28:56
	Publish Date:		2021-02-18 09:00:00
	Description:		Magic mushrooms, LSD and ketamine used to be associated with psychedelic trips and fun weekends. Now they’re increasingly viewed as serious medicine that can be used to treat ailments such as depression and PTSD. The small but fast-growing industry even has its first ETF — the Canadian-listed Horizons Psychedelic Stock ETF, or PSYK. On this episode of Trillions, Eric and Joel speak with Steve Hawkins, the CEO of the firm behind the ETF, who was also behind the world’s first cannabis ETF. He talks the about sector outlook, underlying business fundamentals, the design of the ETF — and whether he plans to start micro-dosing LSD. See omnystudio.com/listener for privacy information.
	Total Play:		0